Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Navas

Showing results (11-20 of 153) with videos related to

Pageof 16
Sort By:
Actas Espanolas De Psiquiatria|January 13, 2010
Advances in attention deficit hyperactivity disorder.What does neuroimaging provide us with?Javier Quintero, M Navas, A Fernández, et al.
Cirugia Espanola|January 20, 2006
[Primary angiosarcoma of the spleen with liver metastases. Case report and literature review]J Verge, J Albiol, M Navas, et al.
Ecotoxicology and Environmental Safety|March 26, 2003
Potencies of estrogenic compounds in in vitro screening assays and in life cycle tests with zebrafish in vivoH Segner, J M Navas, C Schäfers, et al.
Gastrointestinal Endoscopy Clinics of North America|November 7, 2018
Symptomatic Management of GastroparesisChristopher M Navas, Nihal K Patel, Brian E Lacy
Nanomaterials (Basel, Switzerland)|September 28, 2023
The Potentiating Effect of Graphene Oxide on the Arylhydrocarbon Receptor (AhR)-Cytochrome P4501A (Cyp1A) System Activated by Benzo(k)fluoranthene (BkF) in Rainbow Trout Cell LineAna Valdehita, María Luisa Fernández-Cruz, José M Navas
Digestive Diseases and Sciences|July 20, 2017
Gastroparesis: Medical and Therapeutic AdvancesChristopher M Navas, Nihal K Patel, Brian E Lacy
Acta Anaesthesiologica Scandinavica|August 13, 2005
Continuous peripheral nerve blockade in lower extremity surgeryA M Navas, T V Gutiérrez, M E Moreno
Alimentary Pharmacology & Therapeutics|January 11, 2019
The willingness of patients with gastroparesis to take risks with medicationsChristopher M Navas, Michael D Crowell, Brian E Lacy
The FEBS Journal|June 8, 2007
Modulation of aryl hydrocarbon receptor transactivation by carbaryl, a nonconventional ligandSusanna Boronat, Susana Casado, José M Navas, et al.
Scandinavian Journal of Gastroenterology|July 31, 2019
Is the double gene dose of DQ2.5 or DQ2.5/DQ2.2 an involved factor in the clinical features of celiac disease?Carmen M Cabrera, Lorenzo Sánchez-Godoy, Víctor M Navas-López
Pageof 16

Showing results (11-20 of 153) with videos related to

Sort By:
Pageof 16
Actas Espanolas De Psiquiatria|January 13, 2010
Advances in attention deficit hyperactivity disorder.What does neuroimaging provide us with?Javier Quintero, M Navas, A Fernández, et al.
Cirugia Espanola|January 20, 2006
[Primary angiosarcoma of the spleen with liver metastases. Case report and literature review]J Verge, J Albiol, M Navas, et al.
Ecotoxicology and Environmental Safety|March 26, 2003
Potencies of estrogenic compounds in in vitro screening assays and in life cycle tests with zebrafish in vivoH Segner, J M Navas, C Schäfers, et al.
Gastrointestinal Endoscopy Clinics of North America|November 7, 2018
Symptomatic Management of GastroparesisChristopher M Navas, Nihal K Patel, Brian E Lacy
Nanomaterials (Basel, Switzerland)|September 28, 2023
The Potentiating Effect of Graphene Oxide on the Arylhydrocarbon Receptor (AhR)-Cytochrome P4501A (Cyp1A) System Activated by Benzo(k)fluoranthene (BkF) in Rainbow Trout Cell LineAna Valdehita, María Luisa Fernández-Cruz, José M Navas
Digestive Diseases and Sciences|July 20, 2017
Gastroparesis: Medical and Therapeutic AdvancesChristopher M Navas, Nihal K Patel, Brian E Lacy
Acta Anaesthesiologica Scandinavica|August 13, 2005
Continuous peripheral nerve blockade in lower extremity surgeryA M Navas, T V Gutiérrez, M E Moreno
Alimentary Pharmacology & Therapeutics|January 11, 2019
The willingness of patients with gastroparesis to take risks with medicationsChristopher M Navas, Michael D Crowell, Brian E Lacy
The FEBS Journal|June 8, 2007
Modulation of aryl hydrocarbon receptor transactivation by carbaryl, a nonconventional ligandSusanna Boronat, Susana Casado, José M Navas, et al.
Scandinavian Journal of Gastroenterology|July 31, 2019
Is the double gene dose of DQ2.5 or DQ2.5/DQ2.2 an involved factor in the clinical features of celiac disease?Carmen M Cabrera, Lorenzo Sánchez-Godoy, Víctor M Navas-López
Pageof 16